Delivery Order SPE2DR25D1017-SPE2DR26F9BRM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $28,198.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed price and no set-aside designation. The award was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare...
- The Defense Logistics Agency has awarded a delivery order valued at $7,892.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-competitive delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $8,603.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) under a firm fixed price contract. The order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,469.83 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is scheduled for ultimate completion on November 18, 2025, with performance of this pharmaceutical delivery occurring at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $3,388.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count package) on December 9, 2025, with completion scheduled for December 10, 2025. This non-competitive, non-set-aside award represents a routine pharmaceutical supply transaction fulfilling federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $35,692.53 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 2, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $56,984.99 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 13, 2025, with completion targeted for November 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $8,931.58 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award utilizes no set-aside designations and falls under a child contract structure. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $95,172.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 26, 2025, with completion targeted for August 27, 2025. This competitive award, issued under firm fixed pricing terms, supports federal medical procurement needs through AmerisourceBergen's established supply chain. The contract specifies performance from the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $18,114.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BRMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8.38K to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count) on December 17, 2025, with completion scheduled for December 18, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is positioned as the prime contractor on this delivery order. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999B through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, medical devices, and specialty pharmaceuticals to military healthcare programs and other federal health systems worldwide. AmerisourceBergen's established federal contract portfolio demonstrates extensive capability in delivering diverse pharmaceutical products across multiple therapeutic domains to defense and civilian health agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 12/16/25 |